Ligand validation:6ABL

ATP: ADENOSINE-5'-TRIPHOSPHATE

ATP is a Ligand Of Interest in 6ABL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ABL_ATP_A_504	99%	27%	0.049	0.979	1.29	1.63	4	5	0	0	100%	1
6AAP_ATP_A_504	100%	41%	0.044	0.984	0.95	1.35	1	3	0	0	100%	1
6ABK_ATP_A_504	99%	33%	0.051	0.986	1.13	1.5	1	5	0	0	100%	1
6AAC_ATP_A_504	99%	34%	0.058	0.985	1	1.6	1	6	0	0	100%	1
6ABM_ATP_A_504	98%	45%	0.057	0.983	0.94	1.19	2	1	0	0	100%	1
6AB1_ATP_A_504	98%	42%	0.062	0.983	0.91	1.33	-	4	0	0	100%	1
2PNN_ATP_A_374	100%	30%	0.027	0.995	1.34	1.43	4	5	2	0	100%	0.9774
5J1T_ATP_A_401	100%	31%	0.03	0.994	1.31	1.43	2	7	0	0	100%	1
1XDN_ATP_A_501	100%	45%	0.03	0.99	1	1.14	2	3	0	0	100%	1
3MHY_ATP_C_113	100%	53%	0.034	0.992	0.86	0.94	-	2	0	0	100%	1
8YN0_ATP_E_601	100%	30%	0.035	0.991	0.88	1.89	-	8	3	0	100%	0.93

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.